Impact of the COVID-19 Pandemic on Initiation of Antibiotic Treatment After Performing a Blood Culture and Intervention by the Antimicrobial Stewardship Team

被引:0
作者
Kubota, Sanae [1 ]
Sasano, Hiroshi [2 ,3 ]
Suzuki, Mai [3 ]
Fukui, Yukiko [3 ]
Chonan, Masayoshi [4 ]
Kawakami, Takaaki [4 ]
Tabe, Yoko [5 ]
Miida, Takashi [5 ]
Kimura, Toshimi [1 ]
Naito, Toshio [3 ]
机构
[1] Juntendo Univ Hosp, Dept Pharm, Tokyo, Japan
[2] Juntendo Tokyo Koto Geriatr Med Ctr, Dept Pharm, Tokyo, Japan
[3] Juntendo Univ, Fac Med, Dept Gen Med, Hongo 2-1-1,Bunkyo Ku, Tokyo 1138421, Japan
[4] Juntendo Univ Hosp, Dept Clin Lab, Tokyo, Japan
[5] Juntendo Univ, Fac Med, Dept Clin Lab Med, Tokyo, Japan
来源
INTERNATIONAL JOURNAL OF GENERAL MEDICINE | 2023年 / 16卷
关键词
coronavirus disease 2019; bacteremia; administration of antibiotics; quality indicator; SEPTIC SHOCK; SEPSIS;
D O I
10.2147/IJGM.S418558
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Whether the coronavirus disease 2019 (COVID-19) pandemic had any effect on the time between blood culture collection and administration of antibiotics in the outpatient Department of Emergency Medicine in a single university hospital in Japan was investigated, and the intervention carried out by the antimicrobial stewardship team (AST) to promote the appropriate use of antibiotics was examined.Patients and Methods: The monthly percentage of patients who visited the outpatient Department of Emergency Medicine between January 2019 and December 2021 and received an intravenous antibiotic within 3 hours of blood culture collection was calculated. The AST calculated a quality indicator (QI) based on the results of the investigation and started QI monitoring and hospital feedback.Results: From January 2020 to March 2021 (the third COVID-19 wave), the implementation rate of antibiotic administration within 3 hours after blood culture collection decreased as the COVID-19 pandemic spread, and the implementation rate tended to increase as the number of COVID-19-positive patients decreased. However, when the AST started monitoring and feedback from April 2021, although there was a temporary decline in the early stages of the fifth wave when the scale of infection was large, the implementation rate rose and was maintained by AST intervention. (the fourth and the fifth COVID-19 waves) (P<0.01). Also, the implementation rate was significantly lower during the COVID-19 pandemic than during the non-pandemic (P<0.05).Conclusion: The early COVID-19 pandemic may have affected the delay in time from blood culture collection to antibiotic administration. Later, in recurring COVID-19 pandemics, AST intervention eliminated this problem. When a bacterial infection such as sepsis is suspected, delayed treatment can be prevented by promptly collecting a blood culture, irrespective of concerns about COVID-19 infection. Calculating the QI may promote AST activities and the appropriate use of antibiotics.
引用
收藏
页码:3713 / 3719
页数:7
相关论文
共 18 条
  • [1] Implementation of earlier antibiotic administration in patients with severe sepsis and septic shock in Japan: a descriptive analysis of a prospective observational study
    Abe, Toshikazu
    Kushimoto, Shigeki
    Tokuda, Yasuharu
    Phillips, Gary S.
    Rhodes, Andrew
    Sugiyama, Takehiro
    Komori, Akira
    Iriyama, Hiroki
    Ogura, Hiroshi
    Fujishima, Seitaro
    Shiraishi, Atsushi
    Saitoh, Daizoh
    Mayumi, Toshihiko
    Naito, Toshio
    Takuma, Kiyotsugu
    Nakada, Taka-aki
    Shiino, Yasukazu
    Tarui, Takehiko
    Hifumi, Toru
    Otomo, Yasuhiro
    Okamoto, Kohji
    Umemura, Yutaka
    Kotani, Joji
    Sakamoto, Yuichiro
    Sasaki, Junichi
    Shiraishi, Shin-ichiro
    Tsuruta, Ryosuke
    Hagiwara, Akiyoshi
    Yamakawa, Kazuma
    Masuno, Tomohiko
    Takeyama, Naoshi
    Yamashita, Norio
    Ikeda, Hiroto
    Ueyama, Masashi
    Gando, Satoshi
    Tasaki, Osamu
    Mizobata, Yasumitsu
    Funakoshi, Hiraku
    Okuyama, Toshiro
    Yamashita, Iwao
    Kanai, Toshio
    Yamada, Yasuo
    Aibiki, Mayuki
    Sato, Keiji
    Yamashita, Susumu
    Yoshida, Kenichi
    Kasaoka, Shunji
    Kon, Akihide
    Rinka, Hiroshi
    Kato, Hiroshi
    [J]. CRITICAL CARE, 2019, 23 (01)
  • [2] Characteristics, management, and in-hospital mortality among patients with severe sepsis in intensive care units in Japan: the FORECAST study
    Abe, Toshikazu
    Ogura, Hiroshi
    Shiraishi, Atsushi
    Kushimoto, Shigeki
    Saitoh, Daizoh
    Fujishima, Seitaro
    Mayumi, Toshihiko
    Shiino, Yasukazu
    Nakada, Taka-aki
    Tarui, Takehiko
    Hifumi, Toru
    Otomo, Yasuhiro
    Okamoto, Kohji
    Umemura, Yutaka
    Kotani, Joji
    Sakamoto, Yuichiro
    Sasaki, Junichi
    Shiraishi, Shin-ichiro
    Takuma, Kiyotsugu
    Tsuruta, Ryosuke
    Hagiwara, Akiyoshi
    Yamakawa, Kazuma
    Masuno, Tomohiko
    Takeyama, Naoshi
    Yamashita, Norio
    Ikeda, Hiroto
    Ueyama, Masashi
    Fujimi, Satoshi
    Gando, Satoshi
    [J]. CRITICAL CARE, 2018, 22
  • [3] Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial
    Alam, Nadia
    Oskam, Erick
    Stassen, Patricia M.
    van Exter, Pieternel
    van de Ven, Peter M.
    Haak, Harm R.
    Holleman, Frits
    van Zanten, Arthur
    van Leeuwen-Nguyen, Hien
    Bon, Victor
    Duineveld, Bart A. M.
    Panday, Rishi S. Nannan
    Kramer, Mark H. H.
    Nanayakkara, Prabath W. B.
    [J]. LANCET RESPIRATORY MEDICINE, 2018, 6 (01) : 40 - 50
  • [4] Bacteremia during COVID-19 pandemic in a tertiary hospital in Spain
    Bayo, Saray Mormeneo
    Ruiz, Maria Pilar Palacian
    Hijazo, Miguel Moreno
    Uson, Maria Cruz Villuendas
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2022, 40 (04): : 183 - 186
  • [5] Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis A Diagnostic Study
    Cheng, Matthew P.
    Stenstrom, Robert
    Paquette, Katryn
    Stabler, Sarah N.
    Akhter, Murtaza
    Davidson, Adam C.
    Gavric, Marko
    Lawandi, Alexander
    Jinah, Rehman
    Saeed, Zahid
    Demir, Koray
    Huang, Kelly
    Mahpour, Amirali
    Shamatutu, Chris
    Caya, Chelsea
    Troquet, Jean-Marc
    Clark, Greg
    Yansouni, Cedric P.
    Sweet, David
    Cheng, Matthew P.
    Stenstrom, Robert
    Paquette, Katryn
    Stabler, Sarah N.
    Akhter, Murtaza
    Davidson, Adam
    Gavric, Marko
    Lawandi, Alexander
    Jinah, Rehman
    Saeed, Zahid
    Demir, Koray
    Huang, Kelly
    Mahpour, Amirali
    Shamatutu, Chris
    Caya, Chelsea
    Troquet, Jean-Marc
    Clark, Greg
    Yansouni, Cedric
    Sweet, David
    Ryan, Emily
    Kadatz, Matthew J.
    Sekhon, Myphinder
    Sangsari, Sassan
    Osati, Farzaneh
    [J]. ANNALS OF INTERNAL MEDICINE, 2019, 171 (08) : 547 - +
  • [6] Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012 (vol 41, pg 580, 2013)
    Dellinger, R. P.
    Levy, M. M.
    Rhodes, A.
    [J]. CRITICAL CARE MEDICINE, 2014, 42 (01) : E88 - E88
  • [7] Evans L, 2021, CRIT CARE MED, V49, P1974, DOI [10.1097/CCM.0000000000005357, DOI 10.1097/CCM.0000000000005357]
  • [8] Harada Taku, 2020, Eur J Case Rep Intern Med, V7, P001940, DOI 10.12890/2020_001940
  • [9] Candel FJ, 2018, REV ESP QUIM, V31, P298
  • [10] Lawrence M., 1997, Eur J Gen Pract, V3, P103, DOI [DOI 10.3109/13814789709160336, 10.3109/13814789709160336]